Gene · 388585
Papers1,519
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,519
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Notch signaling activation reduces vesicular endocytosis in human pluripotent stem cell-derived CNS-like endothelial cells. | Fluids Barriers CNS | 2026 | 41546116 | PubTator, text mining | PubMed |
| Comprehensive molecular profiling of combined hepatocellular carcinoma and cholangiocarcinoma reveals distinct Notch signaling subgroups with prognostic significance. | Virchows Arch | 2026 | 40637792 | PubTator, text mining | PubMed |
| Low SVEP1 in intrahepatic cholangiocarcinoma mediates phenotype switching-driven metastasis by Jag2/Notch1/Hes5. | Cell Death Dis | 2025 | 41315239 | PubTator, text mining | PubMed |
| Enhanced Notch dependent gliogenesis and delayed physiological maturation underlie neurodevelopmental defects in Lowe syndrome. | EMBO Mol Med | 2025 | 41219536 | PubTator, text mining | PubMed |
| White Matter in Crisis: Oligodendrocytes and the Pathophysiology of Multiple Sclerosis. | Cells | 2025 | 41002375 | PubTator, text mining | PubMed |
| Transcriptomic and lipidomic profiling provide novel insight into the pathogenesis of monogenic SGMS2-related osteoporosis. | JBMR Plus | 2025 | 40978119 | PubTator, text mining | PubMed |
| Reversion of aortic valve cells calcification by activation of Notch signalling via histone acetylation induction. | Signal Transduct Target Ther | 2025 | 40962819 | PubTator, text mining | PubMed |
| CUT&TIME captures the history of open chromatin in developing neurons. | bioRxiv | 2025 | 40950047 | PubTator, text mining | PubMed |
| Metformin alters mitochondria-related metabolism and enhances human oligodendrocyte function. | Nat Commun | 2025 | 40885740 | PubTator, text mining | PubMed |
| AS04 drives superior cross-protective antibody response by increased NOTCH signaling of dendritic cells and proliferation of memory B cells. | Front Immunol | 2025 | 40808939 | PubTator, text mining | PubMed |
| NINJ1 exerts a role in the development of preeclampsia through potential regulation by the Notch1 signaling pathway. | J Obstet Gynaecol Res | 2025 | 40289260 | PubTator, text mining | PubMed |
| Hes5+ astrocytes potentiate primary afferent Aδ and C fiber-mediated excitatory synaptic transmission to spinal lamina I neurons. | Mol Brain | 2025 | 40289116 | PubTator, text mining | PubMed |
| Identification and characterization of mitochondrial autophagy-related genes in osteosarcoma and predicting clinical prognosis. | Sci Rep | 2025 | 40128298 | PubTator, text mining | PubMed |
| The combinatorial binding syntax of transcription factors in forebrain-specific enhancers. | Biol Open | 2025 | 39976127 | PubTator, text mining | PubMed |
| Comparative Analysis of Transcription Factors TWIST2, GATA3, and HES5 in Glioblastoma Multiforme : Evaluating Biomarker Potential and Therapeutic Targets Using in Silico Methods. | J Korean Neurosurg Soc | 2025 | 39444320 | PubTator, text mining | PubMed |
| Region-Specific Transcriptional Signatures of Brain Aging in the Absence of Neuropathology at the Single-cell Level. | bioRxiv | 2025 | 37577533 | PubTator, text mining | PubMed |
| Current advances in the development of microRNA-integrated tissue engineering strategies: a cornerstone of regenerative medicine. | Front Bioeng Biotechnol | 2024 | 39479296 | PubTator, text mining | PubMed |
| Limited Adipogenic Differentiation Potential of Human Dental Pulp Stem Cells Compared to Human Bone Marrow Stem Cells. | Int J Mol Sci | 2024 | 39456888 | PubTator, text mining | PubMed |
| Reassessment of marker genes in human induced pluripotent stem cells for enhanced quality control. | Nat Commun | 2024 | 39358374 | PubTator, text mining | PubMed |
| Methylated DNA Markers in Voided Urine for the Identification of Clinically Significant Prostate Cancer. | Life (Basel) | 2024 | 39202766 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/388585/papers?page=2